Loading...
Powered By
8 items
2025-05-20
TearExo announced that it has received round of funding from new investor Soken Chemical & Engineering Co., Ltd. on May 14, 2025.
2025-05-15
Soken Chemical & Engineering Co., Ltd., Annual General Meeting, Jun 25, 2025.
2025-02-28
Soken Chemical & Engineering Co., Ltd. announced that they will report fiscal year 2025 results on May 15, 2025
2025-02-28
Soken Chemical & Engineering Co., Ltd. announced that they will report Q1, 2026 results on Aug 05, 2025
2025-02-19
Soken Chemical & Engineering Co., Ltd., 2 : 1, Stock Split or Significant Stock Dividend, Mar-28-2025
2025-02-05
Soken Chemical & Engineering Co., Ltd. expected to report Fiscal Year 2025 results on May 13, 2025. This event was calculated by S&P Global (Created on February 5, 2025).
2024-11-06
Soken Chemical & Engineering Co., Ltd., ¥ 125., Cash Dividend, Mar-28-2025
2024-09-24
Soken Chemical & Engineering Co., Ltd.(TSE:4972) added to S&P Global BMI Index
2025Q2 | 2025Q1 | 2024Q4 | 2024Q3 | 2024Q2 | 2024Q1 | 2023Q4 | 2023Q3 | |
|---|---|---|---|---|---|---|---|---|
Total Revenues | 47,355 | 47,633 | 45,510 | 46,394 | 43,929 | 41,318 | 40,049 | 37,929 |
Pretax Income Excl.Unusual Items | 5,826 | 6,339 | 5,828 | 5,763 | 5,028 | 3,908 | 3,637 | 2,491 |
Total Assets | 52,638 | 54,114 | 52,890 | 55,210 | 52,929 | 50,582 | 50,137 | 48,944 |
Total Liabilities | 15,563 | 16,112 | 16,462 | 18,730 | 18,579 | 17,848 | 17,410 | 17,637 |
Cash & Cash Equivalents | 6,601 | 8,413 | 7,256 | 7,937 | 6,583 | 7,576 | 6,964 | 6,036 |
Total Common Equity | 37,075 | 38,002 | 36,428 | 36,480 | 34,350 | 32,734 | 32,727 | 31,307 |
Book Value Per Share (BVPS) | 2,236.13 | 2,292.04 | 2,197.08 | 2,200.22 | 2,073.88 | 1,976.31 | 3,951.76 | 3,780.28 |
Net Change in Cash | 2,837 | 3,401 | 3,063 | 1,175 | ||||
Capital Expenditure | -1,490 | -1,797 | -2,263 | -2,999 |
Soken Chemical & Engineering revealed its financial results for the second quarter of 2025 on August 05, 2025, with revenues of 11.38B yen and net income of 958M yen, indicating a decline of 2.4% in revenue, along with a significant decline of approximately 34.2% in EPS compared to the same quarter last year.
Additionally, the EBITDA margin experienced a slight decrease from 19.7% in the corresponding quarter last year to 17.9%. and it trades at 7.2x times current year's earnings, which is lower than the sector average (P/E 13.4x).